COMMUNIQUÉS West-GlobeNewswire

India Globalization Capital Reports Promising Spatial Memory Results in Alzheimer’s Study
02/01/2018
BETHESDA, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vivo data compiled from genetically engineered mice to mimic Alzheimer’s shows marked improvement [...]
Atara Biotherapeutics Announces Initiation of Two Phase 3 Clinical Studies to Evaluate Tabelecleucel in Patients with Rituximab-Refractory Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder (EBV+PTLD)
02/01/2018
– Three clinical sites for both the MATCH and ALLELE pivotal studies now open for enrollment in the U.S. – SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a [...]
Inovalon to Present at 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
BOWIE, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
Arch Therapeutics to Provide Corporate Update at The 10th Annual Biotech Showcase™ 2018 Conference on January 8th, 2018
02/01/2018
FRAMINGHAM, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Merus to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
UTRECHT, The Netherlands, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ: MRUS ), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, today announced that Ton [...]
Spark Therapeutics to Participate in Multiple Conferences in January
02/01/2018
PHILADELPHIA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that Jeffrey D. [...]
Aptose Biosciences to Present at Biotech Showcase™ 2018 Conference
02/01/2018
SAN DIEGO and TORONTO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms [...]
Agios to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018
02/01/2018
CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the company is [...]
BioCorRx CEO, Brady Granier, Appears on Fox & Friends to Discuss the Opioid Epidemic
02/01/2018
ANAHEIM, CA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]
G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
RESEARCH TRIANGLE PARK, N.C., Jan. 02, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D., will [...]
Apellis Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]
Melinta Therapeutics Appoints Lisa DeFrancesco as Senior Vice President of Investor Relations
02/01/2018
NEW HAVEN, Conn., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing, and commercializing novel antibiotics to treat serious bacterial [...]
NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development
02/01/2018
Series A financing co-led by ArrowMark Partners and Barer & Son Capital Financing supports initiation of Phase I/II trial of AIM TM ACT in relapsed/refractory Hematologic Malignancies in 2018 GAITHERSBURG, Md., Jan [...]
Genmab to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
Media Release Copenhagen, Denmark; January 2, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 36 th Annual J.P. Morgan Healthcare [...]
Coherus BioSciences Management to Present at The 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
REDWOOD CITY, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that senior management will present at the 36 th annual J.P. Morgan healthcare conference on Monday, [...]
Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
02/01/2018
SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced that Scott Struthers, Ph.D [...]
Predictive Technology Group Appoints Dr. Michael Dey To Board Of Directors
02/01/2018
SALT LAKE CITY, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), announces the appointment of Michael Dey, Ph.D. to the Board of Directors of Predictive Technology Group, Inc. Dr. Dey [...]
Progenics Pharmaceuticals Completes Enrollment in Phase 3 Study of PSMA-Targeted Imaging Agent 1404
02/01/2018
NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, today [...]
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
02/01/2018
SEATTLE, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced that it received a product-specific pediatric waiver from the European [...]

Pages